Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Lincoln Pharmaceuticals Ltd
LINCOLN | NSE
605.55
INR-5.90
-0.96%
LINCOLN | NSE
Loading StockChartView...
About Lincoln Pharmaceuticals Ltd
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
24/04/2026
Close
605.55
Open
611.85
High
619.55
Low
600.00
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold anti-allergic and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins minerals and antioxidants; anti-bacterial anti-viral and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic anti-convulsant anti-depressant and anti-diabetic; cardiac anti-hypertensives and diuretic; and anti-diarrheal anti-spasmodic and laxative as well as dermatologist preparations gynecological products gastrointestinal rang otology products and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics. The company was incorporated in 1979 and is based in Ahmedabad India.
View LessLINCOLN | NSE
Risk
47.4
Sharpe
0.02
Luna's Score
58/100
Recommendation
Hold
Luna says (LINCOLN | NSE)
What's Working
Positive Momentum
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
40.2%1 month
47.4%3 months
54.7%6 months
42.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
13.55
Fwd. PE
-
Price to book
2.23
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
8.75
Ent. to rev.
2.05
PEG
-
Other Fundamentals
EBITDA
1.02B
MarketCap
12.13B
MarketCap(USD)
126.75M
Div. yield
0.27
Op. margin
13.25
Erngs. growth
24.60
Rev. growth
8.60
Ret. on equity
17.04
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
86.10
Range1M
89.50
Range3M
237.00
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.31
Price X volume
8.88M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.75 | 24.85 | Cheaper |
| Ent. to Revenue | 2.05 | 11.40 | Cheaper |
| PE Ratio | 13.55 | 51.36 | Cheaper |
| Price to Book | 2.23 | 6.83 | Cheaper |
| Dividend Yield | 0.27 | 0.52 | Poor |
| Std. Deviation (3M) | 54.74 | 42.17 | Riskier |
| Debt to Equity | 0.00 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 12.13B | 290.82B | Emerging |
